Skip to main content
News Directory 3
  • Business
  • Entertainment
  • Health
  • News
  • Sports
  • Tech
  • World
Menu
  • Business
  • Entertainment
  • Health
  • News
  • Sports
  • Tech
  • World

Neuroinflammation Persists in Long COVID for 2 Years

September 12, 2025 Jennifer Chen Health
News Context
At a glance
  • This study is a significant step forward in understanding the biological basis of long COVID.
  • Radiotracer Used: F-18 DPA-714 (binds‍ to translocator protein/TSPO, a biomarker for neuroinflammation)
  • Key Finding: ⁤ Significantly higher binding in global grey matter in ⁢the long COVID group⁤ (0.8 ± 0.34) compared to the control group ⁢(0.65 ± ⁤0.17,p = 0.036).
Original source: auntminnie.com

Neuroinflammation in Long COVID: Key Facts

  • What: PET imaging reveals neuroinflammation (specifically, ‍increased translocator protein/TSPO activity) ⁣in some individuals with long COVID.
  • Where: Amsterdam UMC (Netherlands) study; imaging performed ‍using PET/CT scanners from philips and Siemens Healthineers.
  • When: Study published September 11, 2023, analyzing data from patients ~2 years post-initial⁢ COVID-19 infection.
  • Why it matters: Provides ⁢*in vivo* evidence of neuroinflammation in long COVID, perhaps identifying an “inflammatory subtype” and offering⁣ a⁣ biomarker (F-18 DPA-714 PET) for diagnosis/monitoring.
  • What’s Next: Further research is needed to understand the long-term effects⁤ of this neuroinflammation and to develop‍ targeted therapies.

– drjenniferchen

This study is a significant step forward in understanding the biological basis of long COVID. ⁣While many theories exist, concrete evidence of ongoing inflammation within ⁤the brain has been lacking. The use of F-18 DPA-714 PET imaging, targeting the TSPO protein, offers ⁣a ⁣promising ⁤avenue for identifying patients with ⁣this ⁣inflammatory component. It’s important to note that‍ not⁣ *all* long COVID patients exhibited this inflammation, suggesting a heterogeneous condition ‍with different underlying mechanisms.The relatively ⁤small sample size warrants larger, multi-centre studies to validate these findings and explore the clinical implications⁤ – for example, whether anti-inflammatory treatments ⁢coudl ⁤benefit this specific subgroup of patients.

Study Details

Group Number of Patients Median Age symptoms
Long ⁤COVID (Severe Fatigue & Concentration ‍Issues) 33 50 Severe fatigue and difficulty concentrating
Previously ⁣Infected, No⁤ Symptoms 14 47 No persistent symptoms

Radiotracer Used: F-18 DPA-714 (binds‍ to translocator protein/TSPO, a biomarker for neuroinflammation)

Imaging Scanners:

  • Philips Ingenuity TF PET/CT (n=10)
  • siemens healthineers Biograph Vision Quadra (n=37)

Key Finding: ⁤ Significantly higher binding in global grey matter in ⁢the long COVID group⁤ (0.8 ± 0.34) compared to the control group ⁢(0.65 ± ⁤0.17,p = 0.036).

Share this:

  • Share on Facebook (Opens in new window) Facebook
  • Share on X (Opens in new window) X

More on this

  • World Hepatitis Day: Prevention, Testing, and Public Health Risks
  • New Ribo-Tweezer Tool Plucks Individual Protein Pieces From Working Ribosomes

Related

Search:

News Directory 3

News Directory 3 catalogs US newspapers, news services, newsstands and digital news outlets across all 50 states. Browse local publishers by city, state, or topic, and follow current headlines linked back to their original sources.

Quick Links

  • Disclaimer
  • Terms and Conditions
  • About Us
  • Advertising Policy
  • Contact Us
  • Cookie Policy
  • Editorial Guidelines
  • Privacy Policy

Browse by State

  • Alabama
  • Alaska
  • Arizona
  • Arkansas
  • California
  • Colorado

© 2026 News Directory 3. All rights reserved.
For contact, advertising, copyright, issues email: office@newsdirectory3.com